A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped responding to chemotherapy, according to a Phase 3 clinical trial by researchers at City of Hope…
For colon cancer that no longer responds to treatment, a new drug combination offers hope

Leave a Comment Leave a Comment
